Latest Innovations
The Latest Life Science Innovations Changing Patients Lives
Click the social share buttons below to keep your network up to date on the latest life science innovations changing patients lives.
Sign Up - Newsletter
Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry
The Latest on Life Science Innovations
The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of March 25, 2026, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are:
-
A newly approved drug, linerixibat, helps reduce severe itching in patients with a rare liver disease (PBC), addressing a major unmet treatment need.
-
The FDA approved teclistamab in combination with daratumumab for relapsed or refractory multiple myeloma, which gives patients more options for treatment.
-
UCLA researchers developed a ready-to-use immunotherapy that showed strong tumor-killing ability against endometrial cancer in early (preclinical) studies, with potential to be more effective and accessible than current treatments.